Enblad G - Search Results

1

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

Luminari S, Fossa A, Trotman J, Molin D, d'Amore F, Enblad G, Berkahn L, Barrington SF, Radford J, Federico M, Kirkwood AA, Johnson PWM. Luminari S, et al. Among authors: enblad g. J Clin Oncol. 2024 Jan 1;42(1):13-18. doi: 10.1200/JCO.23.01177. Epub 2023 Oct 26. J Clin Oncol. 2024. PMID: 37883739 Free PMC article. Clinical Trial.

2

Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.

Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, Venge P, Nilsson K, Sundström C, Enblad G, Nilsson G. Molin D, et al. Among authors: enblad g. Br J Haematol. 2001 Sep;114(3):616-23. doi: 10.1046/j.1365-2141.2001.02977.x. Br J Haematol. 2001. PMID: 11552987 Free article.

3

The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.

Molin D, Glimelius B, Sundström C, Venge P, Enblad G. Molin D, et al. Among authors: enblad g. Leuk Lymphoma. 2001 Jul;42(3):457-65. doi: 10.3109/10428190109064602. Leuk Lymphoma. 2001. PMID: 11699410

4

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.

Molin D, Edström A, Glimelius I, Glimelius B, Nilsson G, Sundström C, Enblad G. Molin D, et al. Among authors: enblad g. Br J Haematol. 2002 Oct;119(1):122-4. doi: 10.1046/j.1365-2141.2002.03768.x. Br J Haematol. 2002. PMID: 12358914 Free article.

5

Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme.

Molin D, Enblad G, Gustavsson A, Ekman T, Erlanson M, Haapaniemi E, Glimelius B; Swedish National Care Programme; Swedish Lymphoma Study Group. Molin D, et al. Among authors: enblad g. Eur J Haematol. 2003 Mar;70(3):172-80. doi: 10.1034/j.1600-0609.2003.00030.x. Eur J Haematol. 2003. PMID: 12605661

6

Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.

Fischer M, Bijman M, Molin D, Cormont F, Uyttenhove C, van Snick J, Sundström C, Enblad G, Nilsson G. Fischer M, et al. Among authors: enblad g. Leukemia. 2003 Dec;17(12):2513-6. doi: 10.1038/sj.leu.2403123. Leukemia. 2003. PMID: 14562126

7

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Glimelius I, Molin D, Amini RM, Gustavsson A, Glimelius B, Enblad G. Glimelius I, et al. Among authors: enblad g. Eur J Haematol. 2003 Nov;71(5):327-33. doi: 10.1034/j.1600-0609.2003.00108.x. Eur J Haematol. 2003. PMID: 14667195

8

IL-9 expression contributes to the cellular composition in Hodgkin lymphoma.

Glimelius I, Edström A, Amini RM, Fischer M, Nilsson G, Sundström C, Enblad G, Molin D. Glimelius I, et al. Among authors: enblad g. Eur J Haematol. 2006 Apr;76(4):278-83. doi: 10.1111/j.1600-0609.2005.00613.x. Eur J Haematol. 2006. PMID: 16519698

9

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.

Hedström G, Berglund M, Molin D, Fischer M, Nilsson G, Thunberg U, Book M, Sundström C, Rosenquist R, Roos G, Erlanson M, Amini RM, Enblad G. Hedström G, et al. Among authors: enblad g. Br J Haematol. 2007 Jul;138(1):68-71. doi: 10.1111/j.1365-2141.2007.06612.x. Br J Haematol. 2007. PMID: 17555448 Free article.

10

The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.

Enblad G, Molin D, Glimelius I, Fischer M, Nilsson G. Enblad G, et al. Hematol Oncol Clin North Am. 2007 Oct;21(5):805-23. doi: 10.1016/j.hoc.2007.07.007. Hematol Oncol Clin North Am. 2007. PMID: 17908621 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page